CCCC
C4 Therapeutics, Inc.
stockNASDAQ
Market OpenNov 12, 2026 9:36:38 AM EST
2.75USD-4.844%(-0.14)48,186
Pre-marketNov 12, 2026 9:21:30 AM EST
2.85USD-1.384%(-0.04)
Loading…
Loading…
360.47M
Healthcare
Biotechnology
HQ
Watertown, MA, USA
146
Previous Close
$2.89
Beta
1.65
52-Week High
$5.17 2026-06-30
52-Week Low
$1.69 2026-02-05
SMA 50
$3.17
SMA 200
$3.24
Avg. Vol 10D
2.69M
Avg. Vol 30D
2.81M
Avg. Vol 90D
2.58M
Relative Vol
0.01
131.32M
100.87M
76.81%
46,580,600
49.29%
15.14
53%/47%
60.12%
37.62%
0.2900%
4,100,000
5,501
6,970
32,532
32.3M
-91.1M
-0.71
-79.7M
-315.86
-47.62
Nov 9, 2026
Nov 6, 2026
Nov 5, 2026
Nov 3, 2026
CCCC Profile
c4 therapeutics is an early stage drug discovery company whose mission is to harness targeted protein degradation to develop therapeutics for a broad range of diseases. the centerpiece of our approach is the degronimid® platform, which enables highly selective small molecule binders to target disease causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system.
CCCC Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.95 | 2026-11-05 | -6.95% | 0.910 |
| 1M | 3.06 | 2026-10-12 | -10.29% | 1.068 |
| 3M | 3.90 | 2026-08-12 | -29.61% | 0.871 |
| 6M | 3.17 | 2026-05-12 | -13.41% | 1.064 |
| 1Y | 2.48 | 2025-11-12 | +10.69% | 1.653 |
| 2Y | 5.51 | 2024-11-12 | -50.18% | — |
| 5Y | 41.83 | 2021-11-12 | -93.44% | 1.984 |
CCCC Stock Summary
C4 Therapeutics, Inc. (NASDAQ:CCCC) stock price today is $2.75, and today's volume is 32,569. CCCC is down 5.017% today. The 30 day average volume is 2.81M. CCCC market cap is $360.47M with 131.32M shares outstanding.